These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25972369)

  • 41. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
    Lüders C; Kristiansen G
    Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
    Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
    World J Urol; 2011 Dec; 29(6):787-92. PubMed ID: 20717829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.
    Poté N; Vieillefond A; Couturier J; Arrufat S; Metzger I; Delongchamps NB; Camparo P; Mège-Lechevallier F; Molinié V; Sibony M
    Virchows Arch; 2013 Jun; 462(6):633-8. PubMed ID: 23708994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Segmental enhancement inversion of small renal oncocytoma: differences in prevalence according to tumor size.
    Woo S; Cho JY; Kim SH; Kim SY; Lee HJ; Hwang SI; Moon MH; Sung CK
    AJR Am J Roentgenol; 2013 May; 200(5):1054-9. PubMed ID: 23617489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Automated differentiation of benign renal oncocytoma and chromophobe renal cell carcinoma on computed tomography using deep learning.
    Baghdadi A; Aldhaam NA; Elsayed AS; Hussein AA; Cavuoto LA; Kauffman E; Guru KA
    BJU Int; 2020 Apr; 125(4):553-560. PubMed ID: 31901213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
    Okoń K; Sińczak-Kuta A
    Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.
    Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multi-Phase Multiple Detector Computed Tomography (MDCT) Enhancement Patterns and Morphological Features of Chromophobe Renal Cell Carcinoma: An Analysis of 67 Cases.
    Luo M; Zhu Y; Chen S; Huang Q; Zhang W; Ma M; Wei Y
    Med Sci Monit; 2021 Apr; 27():e929287. PubMed ID: 33907175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
    Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
    Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical analysis of cytochrome C oxidase facilitates differentiation between oncocytoma and chromophobe renal cell carcinoma.
    Adam AC; Scriba A; Ortmann M; Huss S; Kahl P; Steiner S; Störkel S; Büttner R
    Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):54-9. PubMed ID: 25265428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiomics analysis based on single phase and different phase combinations of radiomics features from tri-phasic CT to distinguish renal oncocytoma from chromophobe renal cell carcinoma.
    Yang S; Jian Y; Yang F; Liu R; Zhang W; Wang J; Tan X; Wu J; Chen Y; Zhou X
    Abdom Radiol (NY); 2024 Jan; 49(1):182-191. PubMed ID: 37907684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma.
    Ohe C; Kuroda N; Takasu K; Senzaki H; Shikata N; Yamaguchi T; Miyasaka C; Nakano Y; Sakaida N; Uemura Y
    Med Mol Morphol; 2012 Jun; 45(2):98-104. PubMed ID: 22718295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.
    Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M
    Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma.
    Demirović A; Džombeta T; Tomas D; Spajić B; Pavić I; Hudolin T; Milošević M; Cupić H; Krušlin B
    Pathol Res Pract; 2010 Oct; 206(10):695-9. PubMed ID: 20591578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A triple-classification for differentiating renal oncocytoma from renal cell carcinoma subtypes and CK7 expression evaluation: a radiomics analysis.
    Yu Z; Ding J; Pang H; Fang H; He F; Xu C; Li X; Ren K
    BMC Urol; 2022 Sep; 22(1):147. PubMed ID: 36096829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabinoid CB1 receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Larrinaga G; Sanz B; Blanco L; Perez I; Candenas ML; Pinto FM; Irazusta A; Gil J; López JI
    Clin Biochem; 2013 May; 46(7-8):638-41. PubMed ID: 23318578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.
    McGillivray PD; Ueno D; Pooli A; Mendhiratta N; Syed JS; Nguyen KA; Schulam PG; Humphrey PA; Adeniran AJ; Boutros PC; Shuch B
    Eur Urol; 2021 Jan; 79(1):107-111. PubMed ID: 32972793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case.
    Pires-Luis A; Montezuma D; Vieira J; Ramalho-Carvalho J; Santos C; Teixeira M; Jerónimo C; Henrique R
    Exp Mol Pathol; 2018 Dec; 105(3):352-356. PubMed ID: 30343009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Ng KL; Morais C; Bernard A; Saunders N; Samaratunga H; Gobe G; Wood S
    J Clin Pathol; 2016 Aug; 69(8):661-71. PubMed ID: 26951082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.